6613.T Stock Surges 30.58% on May 8, 2026 – QD Laser Gains

QD Laser, Inc. (6613.T) delivered a powerful performance on May 8, 2026, with 6613.T stock climbing 30.58% to close at ¥1,853 on the JPX exchange. The semiconductor laser specialist saw trading volume surge to 21.6 million shares, nearly 2.2 times its average daily volume. This sharp rally reflects growing investor confidence in the company’s laser device and medical eyewear segments. The stock has now gained 426.57% over the past year, establishing itself as one of Japan’s most dynamic technology plays. We examine the drivers behind this momentum and what it means for the semiconductor sector.

Strong Price Action and Trading Momentum

The 6613.T stock opened at ¥1,500 and climbed steadily throughout the session, reaching an intraday high of ¥1,895 before settling at ¥1,853. This represents a ¥434 gain from the previous close of ¥1,419. The 50-day moving average sits at ¥1,219.82, while the 200-day average stands at ¥590.35, showing sustained upward momentum across multiple timeframes.

Volume activity tells a compelling story. Today’s 21.6 million shares traded far exceeded the 9.9 million average, indicating strong institutional and retail participation. The relative volume ratio of 0.69 suggests this surge came from genuine buying interest rather than forced liquidation. Technical indicators support the bullish setup, with the RSI at 57.91 indicating room for further gains without overbought conditions.

Market Sentiment and Technical Setup

Trading Activity

The semiconductor sector on JPX showed broad strength today, with QD Laser outpacing peers. The company’s market cap now stands at ¥62.9 billion, reflecting its growing importance in the laser technology space. The stock trades at a price-to-sales ratio of 46.01x, elevated but justified by growth expectations in silicon photonics and medical applications.

Liquidation

Cash position remains robust at ¥73.51 per share, providing a financial cushion. The current ratio of 17.51x demonstrates exceptional liquidity, with minimal debt concerns. The debt-to-equity ratio of just 0.0008 shows QD Laser operates with virtually no leverage, positioning it well for sustained growth investments without financial strain.

Business Segments Driving Growth

QD Laser operates two core business divisions that fuel investor enthusiasm. The Laser Device Business produces semiconductor lasers and epitaxial wafers used in telecommunications, manufacturing, and precision machining. These products serve the expanding silicon photonics market, where demand continues accelerating as data centers scale globally.

The Laser Eyewear Business represents the company’s innovative medical division. Products like RETISSA display II and RETISSA medical devices apply laser retinal projection technology for vision correction and eye health monitoring. This segment taps into aging demographics across developed markets, creating long-term revenue streams. Track 6613.T on Meyka for real-time updates on segment performance and earnings announcements.

Financial Metrics and Valuation Context

Profitability Challenges

QD Laser currently reports negative earnings, with EPS of -¥7.38 and a PE ratio of -204.07. Net profit margin stands at -24.93%, reflecting heavy R&D spending at 12.65% of revenue. However, gross profit margin of 40.29% demonstrates strong underlying unit economics. The company prioritizes growth and innovation over near-term profitability, a common strategy for semiconductor specialists.

Growth Trajectory

Year-over-year metrics show promise. Revenue grew 4.92%, while gross profit surged 38.93%. Operating income climbed 26.21%, and net income improved 30.63% despite remaining negative. EPS growth of 30.83% signals improving operational efficiency. These trends suggest the company is moving toward profitability as scale increases and R&D investments mature into commercial products.

Final Thoughts

QD Laser’s 30.58% surge reflects strong momentum in semiconductor lasers and medical devices. The 352.25% year-to-date gain shows sustained investor confidence despite current losses. Strong gross margins, minimal debt, and robust cash reserves support future growth. The company’s focus on telecommunications and medical eyewear positions it well in high-growth markets. While unprofitable, improving operational metrics suggest progress. Investors should watch the May 14 earnings announcement for commercialization updates. The technical setup remains constructive, though valuations already reflect significant growth expectations.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.